Nasrin Rastgoo

Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS

Nasrin Rastgoo, Maryam Pourabdollah, Jahangir Abdi et al. · Leukemia · 2018 · 75 citations

Hematological Malignancy, Tumor Biology, Health Sciences +12

Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma

Nasrin Rastgoo, Jian Wu, Mariah Liu et al. · Haematologica · 2019 · 63 citations · Full text

Medicine, Tumor Growth, Immunology +13

Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine

Christine Hartoonian, Massoumeh Ebtekar, Hoorieh Soleimanjahi et al. · Cytokine · 2009 · 31 citations

Vaccination, Autoimmune Disease, Vaccine Development +12

Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells

Jahangir Abdi, Nasrin Rastgoo, Yan Chen et al. · BMC Cancer · 2019 · 24 citations · Full text

A Phase 1a/b Dose Escalation Study of the MYC Repressor Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS

Maro Ohanian, Martha Arellano, Moshe Levy et al. · Blood · 2021 · 15 citations